Vivos Therapeutics Inc. (NASDAQ: VVOS)
$4.3700
N/A ( +0.23% ) 317.6K
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Market Data
Open
$4.3700
Previous close
$4.3700
Volume
317.6K
Market cap
$25.74M
Day range
$4.0620 - $4.5950
52 week range
$1.9100 - $9.1391
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 19 | Dec 23, 2024 |
4 | Insider transactions | 1 | Nov 27, 2024 |
8-k | 8K-related | 13 | Nov 27, 2024 |
4 | Insider transactions | 1 | Nov 27, 2024 |
10-q | Quarterly Reports | 70 | Nov 14, 2024 |
8-k | 8K-related | 14 | Nov 14, 2024 |
def | Proxies and info statements | 4 | Oct 07, 2024 |
8-k | 8K-related | 18 | Sep 20, 2024 |
8-k | 8K-related | 14 | Sep 18, 2024 |
8-k | 8K-related | 13 | Sep 17, 2024 |